BrainCool AB (publ)
BrainCool AB (publ) develops and commercializes medical cooling systems for neuroprotection in stroke and other neurological conditions, generating revenue primarily through product sales and service contracts.
Business. BrainCool AB (publ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, with its financial performance tracked through metrics such as organic revenue growth, procedure volume, and gross margin. BrainCool is headquartered in Sweden and is listed on the Nasdaq Stockholm exchange under the ticker symbol BRAIN.ST. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BrainCool AB (publ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, with its financial performance tracked through metrics such as organic revenue growth, procedure volume, and gross margin. BrainCool is headquartered in Sweden and is listed on the Nasdaq Stockholm exchange under the ticker symbol BRAIN.ST. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.
BrainCool operates with a strong equity base, as evidenced by a price-to-book ratio of 1.8 and a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is robust, with a current ratio of 7.03, suggesting ample short-term assets to cover liabilities. However, the company's operating cash flow of -52.7 million SEK and free cash flow of -39.4 million SEK highlight significant cash outflows, primarily driven by its operating losses.
Profitability metrics are underperforming relative to industry norms. BrainCool reported a net loss of 37.1 million SEK and an operating loss of 34.4 million SEK, resulting in a return on equity of -21.1% and a return on assets of -19.3%. These figures indicate that the company is not generating returns that meet the cost of capital, a concern for investors seeking value creation.
The company's revenue is concentrated in a single business line focused on neuroprotection cooling systems, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification increases exposure to market-specific risks, particularly in the healthcare equipment sector, which is subject to regulatory and reimbursement pressures.
Looking ahead, BrainCool's growth trajectory is uncertain. The company has not provided specific revenue growth projections, and its historical performance shows a consistent pattern of losses. Analysts have assigned a mean price target of 1.00 SEK, with a strong buy recommendation, but the absence of a clear path to profitability raises questions about the sustainability of this outlook.
Risk factors include the company's reliance on a single product line and the absence of long-term debt, which, while reducing financial leverage risk, also limits access to capital for growth initiatives. The risk assessment indicates low dilution and liquidity risks, but the company's operating cash flow and free cash flow remain negative, signaling ongoing operational challenges.
Recent filings and transcripts do not reveal any material events that would significantly alter the company's risk profile or growth prospects. The absence of immediate liquidity or dilution flags is a positive, but the company's financial performance remains a key area of concern for investors.
- BrainCool has a strong equity position and no long-term debt, but it is experiencing significant operating and net losses.
- The company's return on equity and return on assets are negative, indicating poor capital efficiency.
- Revenue is concentrated in a single product line with no geographic diversification disclosed.
- Analysts have a positive outlook with a mean price target of 1.00 SEK, but the company's path to profitability is unclear.
- The company's liquidity position is strong, but its operating cash flow and free cash flow remain negative.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,06 |
| Revenue | —no estimate | —no estimate | 54,0M SEK |
| Operating income | —no estimate | —no estimate | -19,0M SEK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Capex To Revenuecapital_expenditure / revenue
- BrainCool AB (publ) Market data — financials · 2026-05-27
- BrainCool AB (publ) Market data — analyst estimates · 2026-05-27